Hjem › Dermatitis › Californien
Dermatitis kliniske forsøg i Californien
6 studier for Dermatitis søger deltagere på steder i Californien.
Byer i Californien
Officiel studietekst (engelsk)
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Fountain Valley
- Novartis Investigative Site, Los Angeles
- Novartis Investigative Site, Sacramento
- og 2 flere
RekruttererFase 2
Alder 18 til 100 · Alle køn · Opdateret 28. sep. 2026 · NCT06947993First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
- Alliance Clinical West Hills (Focus Clinical Research), West Hills
RekruttererFase 1Frivillige med god helbredstilstand velkomne
Alder 18 til 65 · Alle køn · Opdateret 25. sep. 2026 · NCT07527923A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
- Investigational Drug Service - Rady Childrens Hospital-San Diego, San Diego
- University of California, San Diego/Rady Children's Hospital-San Diego; Pediatric & Adolescent Derm, San Diego
RekruttererFase 3
Alder 6 til 11 · Alle køn · Opdateret 25. sep. 2026 · NCT06807268A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
- Northridge Clinical Trials, Northridge
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT07765888A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Marvel Research, LLC, Huntington Beach
- Metropolis Dermatology, Los Angeles
- Dermatology Research Associates, Los Angeles
- og 4 flere
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 28. aug. 2026 · NCT07599813A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 1, Lancaster
- Inmagene Site 23, Los Angeles
RekruttererFase 2
Alder 18 til 74 · Alle køn · Opdateret 12. aug. 2026 · NCT07037901Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.